Cargando…
Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model
Antiglycolytic agents inhibit cell metabolism and modify the tumor’s microenvironment, affecting chemotherapy resistance mechanisms. In this work, we studied the effect of the glycolytic inhibitors 3-bromopyruvate (3BP), dichloroacetate (DCA) and 2-deoxyglucose (2DG) on cancer cell properties and on...
Autores principales: | Cunha, Andrea, Rocha, Ana Catarina, Barbosa, Flávia, Baião, Ana, Silva, Patrícia, Sarmento, Bruno, Queirós, Odília |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611291/ https://www.ncbi.nlm.nih.gov/pubmed/36297455 http://dx.doi.org/10.3390/pharmaceutics14102021 |
Ejemplares similares
-
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
por: Cunha, Andrea, et al.
Publicado: (2023) -
Increasing the Power of Polyphenols through Nanoencapsulation for Adjuvant Therapy against Cardiovascular Diseases
por: Trindade, Lucileno Rodrigues, et al.
Publicado: (2021) -
Nanoencapsulation for drug delivery
por: Kumari, Avnesh, et al.
Publicado: (2014) -
Nanoencapsulation Strategies for Active Compounds Delivery
por: Carbone, Claudia, et al.
Publicado: (2022) -
Nanoencapsulation as a novel delivery approach for therapeutic applications of gla-rich protein (GRP)
por: Araújo, Nuna, et al.
Publicado: (2021)